Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
영국 런던, Dec. 07, 2017 (GLOBE NEWSWIRE) -- 칸나비노이드 제품 플랫폼을 통해 신종 치료법 발굴과 개발, 상용화에 주력하는 바이오제약기업 GW Pharmaceuticals (나스닥: GWPH) (이하 GW)이 2억 2,500만 달러 상당의 미국예탁증권(ADS) 매각을 검토 중이라고 오늘 발표했다. GW의 보통주에 상응하는 해당...
-
LONDON, Dec. 07, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals Mengumumkan Cadangan Penawaran Awam bagi ADS LONDON, 5 Disember 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) ("GW" atau...
-
伦敦, Dec. 07, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc（Nasdaq:GWPH）（“GW”或“公司”）是一家生物制药公司，致力于研究、开发其专有大麻素产品平台的新型疗法并进行商品化。该公司今日宣布，计划以美国包销公开发行方式出售2.25亿美元的美国存托股票（“ADS”），作为GW在纳斯达克全球市场（NASDAQ Global...
-
倫敦, Dec. 07, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc（Nasdaq:GWPH）（「GW」或「公司」）是一家生物製藥公司，致力於研究和開發其專有大麻素產品平台的新型療法並進行商業化。該公司今天宣佈，計劃以美國承銷公開發售方式出售2.25億美元的美國預託股份（「ADS」），作為GW在納斯達克全球市場（NASDAQ Global...
-
ンドン発, Dec. 07, 2017 (GLOBE NEWSWIRE) -- 独自のカンナビノイド製品プラットフォームからの新薬の発見･開発･製品化に特化しているバイオ製薬会社であるGWファーマシューティカルズ (GW Pharmaceuticals plc、NASDAQ:GWPH) (以下「GW」または「同社」)...
-
LONDRES, Dec. 06, 2017 (GLOBE NEWSWIRE) -- A GW Pharmaceuticals plc (Nasdaq:GWPH) ("GW" ou a “Empresa”), uma empresa biofarmacêutica focada na descoberta, no desenvolvimento e na comercialização de...
-
LONDON, Dec. 05, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) ("GW" or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel...
-
- Epidiolex® (cannabidiol) NDA Submitted to FDA -- Conference call today at 7:30 a.m. EST - LONDON and CARLSBAD, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (GW,...
-
LONDON, Nov. 27, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel...
-
– 29th Annual Piper Jaffray Healthcare Conference on November 29, 2017 – – Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference on November 30, 2017 – LONDON, Nov. 22, 2017 (GLOBE NEWSWIRE)...